Skip to main content

funding-money-invest-pixa

Biopharma venture capital activity maintained its red-hot pace during the third quarter of 2018, driven by a handful of deals exceeding $200 million, according to a report released this week.

{iframe}https://www.genengnews.com/gen-news-highlights/vc-investment-jumps-51-year-over-year-during-q3/81256318/?utm_medium=newsletter&utm_source=gen+daily+news+highlights&utm_content=01&utm_campaign=gen+daily+news+highlights_20181010&oly_enc_id=1673d8247356b7u&ajs_trait_oebid=9675b9130356b7s{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.